Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7258550

Concept As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
789,619,000,000 JPY
688,435,000,000 JPY
613,566,000,000 JPY
542,568,000,000 JPY
545,553,000,000 JPY
Ordinary profit (loss)
431,119,000,000 JPY
373,257,000,000 JPY
338,241,000,000 JPY
270,544,000,000 JPY
223,433,000,000 JPY
Net assets
1,366,867,000,000 JPY
1,183,824,000,000 JPY
1,022,834,000,000 JPY
873,622,000,000 JPY
787,715,000,000 JPY
Total assets
2,559,271,000,000 JPY
2,458,895,000,000 JPY
1,488,925,000,000 JPY
1,388,556,000,000 JPY
1,350,771,000,000 JPY
Net assets per share
763.31
660.00
568.97
477.81
424.69
Basic earnings (loss) per share
178.59
162.92
172.64
121.69
103.95
Diluted earnings per share
178.55
162.87
172.57
121.63
103.89
Equity-to-asset ratio
0.534 xbrli:pure
0.481 xbrli:pure
0.687 xbrli:pure
0.629 xbrli:pure
0.583 xbrli:pure
Rate of return on equity
0.251 xbrli:pure
0.265 xbrli:pure
0.332 xbrli:pure
0.271 xbrli:pure
0.265 xbrli:pure
Price-earnings ratio
8.1 xbrli:pure
10.1 xbrli:pure
10.9 xbrli:pure
15.7 xbrli:pure
16.4 xbrli:pure
Number of employees
13,643 xbrli:pure
4,105 xbrli:pure
13,643 xbrli:pure
4,105 xbrli:pure
14,754 xbrli:pure
4,806 xbrli:pure
4,867 xbrli:pure
14,484 xbrli:pure
14,522 xbrli:pure
3,943 xbrli:pure
15,455 xbrli:pure
4,647 xbrli:pure
Revenue
1,912,323,000,000 JPY
1,603,672,000,000 JPY
1,518,619,000,000 JPY
1,296,163,000,000 JPY
1,249,528,000,000 JPY
Profit (loss) before tax
31,237,000,000 JPY
24,969,000,000 JPY
132,361,000,000 JPY
156,886,000,000 JPY
145,324,000,000 JPY
Profit (loss), attributable to owners of parent
50,747,000,000 JPY
17,045,000,000 JPY
98,714,000,000 JPY
124,086,000,000 JPY
120,589,000,000 JPY
Comprehensive income, attributable to owners of parent
48,888,000,000 JPY
205,583,000,000 JPY
205,277,000,000 JPY
208,117,000,000 JPY
181,499,000,000 JPY
Equity attributable to owners of parent
1,513,255,000,000 JPY
1,595,988,000,000 JPY
1,507,954,000,000 JPY
1,460,308,000,000 JPY
1,386,115,000,000 JPY
Total assets
3,339,544,000,000 JPY
3,569,603,000,000 JPY
2,456,518,000,000 JPY
2,332,395,000,000 JPY
2,273,628,000,000 JPY
Owners' equity per share
845.25
890.07
839.26
799.26
748.03
Basic earnings (loss) per share
28.35
9.51
54.24
67.08
64.93
Diluted earnings (loss) per share
28.24
9.47
54.09
67.05
64.90
Ratio of owners' equity to gross assets
0.453 xbrli:pure
0.447 xbrli:pure
0.614 xbrli:pure
0.626 xbrli:pure
0.610 xbrli:pure
Rate of return on equity
0.033 xbrli:pure
0.011 xbrli:pure
0.067 xbrli:pure
0.087 xbrli:pure
0.090 xbrli:pure
Price-earnings ratio
51.0 xbrli:pure
172.9 xbrli:pure
34.7 xbrli:pure
28.5 xbrli:pure
26.2 xbrli:pure
Cash flows from (used in) operating activities
194,512,000,000 JPY
172,475,000,000 JPY
327,767,000,000 JPY
257,444,000,000 JPY
306,843,000,000 JPY
Cash flows from (used in) investing activities
-89,419,000,000 JPY
-845,802,000,000 JPY
-84,500,000,000 JPY
-62,413,000,000 JPY
-81,894,000,000 JPY
Cash flows from (used in) financing activities
-261,367,000,000 JPY
614,060,000,000 JPY
-195,623,000,000 JPY
-216,298,000,000 JPY
-229,479,000,000 JPY
Cash and cash equivalents
188,372,000,000 JPY
335,687,000,000 JPY
376,840,000,000 JPY
315,986,000,000 JPY
326,128,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.